Phase I of first-in-human clinical trial of bifunctional immunotherapeutic for advanced solid tumor cancers
Physicians and scientists at the University of Minnesota have opened a new solid tumor cancer clinical trial and have treated their first patient with HCW9218, an injectable, bifunctional immunotherapeutic, developed by HCW ...
May 20, 2022
0
2